Immunosuppressive therapy in patients with IgA nephropathy

Area of Science:

• Nephrology
• Immunology

Background:

• Limited evidence supports cytotoxic therapy for IgA nephropathy with renal insufficiency.
• This study investigates the efficacy and predictors of response to cytotoxic therapy in such patients.

Purpose of the Study:

• To evaluate the effect of cytotoxic therapy on IgA nephropathy patients with renal insufficiency.
• To identify predictors of treatment response.

Main Methods:

• Retrospective analysis of 19 patients with IgA nephropathy treated with cytotoxic agents and prednisone.
• Primary outcome: progression of renal disease (≥50% increase in serum creatinine or end-stage renal disease).

Main Results:

• Nine of 19 patients showed stable estimated glomerular filtration rate (eGFR); ten had progressive disease.
• Proteinuria reduction ≥50% to <1 g/day within six months predicted favorable long-term response (8/9 responders vs. 3/10 non-responders, p < 0.01).

Conclusions:

• Prolonged immunosuppressive therapy with cytotoxic agents and prednisone may benefit a subgroup of IgA nephropathy patients.
• Early proteinuria reduction is a strong predictor of long-term treatment success.